Magic mushrooms (or more scientifically, psilocybin mushrooms) should be rescheduled from Schedule I (“no medical benefit”) to Schedule IV (drugs that require a prescription but that are considered to have a low potential for abuse or dependence), say Johns Hopkins University researchers.
In the October edition of Neuropharmacology, a group of researchers present their findings, saying that the naturally-occurring fungi have a low potential for abuse or dependence, according to a report on the university’s website.
Currently, the Food and Drug Administration lists psilocybin mushrooms on Schedule I of the Controlled Substances List. That means that it is deemed to have “no medical value” and shares its spot on the list with methamphetamines, heroin, crack, and cannabis.
However, Matthew W. Johnson, associate professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, wants that to change.
0 comments :
Post a Comment